Efficacy of thrice-daily versus twice-daily insulin regimens on glycohemoglobin (Hb A1c) in type 1 diabetes mellitus: A randomized controlled trial

Oman Medical Journal

Volumn 26, Issue 1, 2011, Pages 10-13

  Razavi, Zahra ^a   Ahmadi, Mehran ^a  

^a HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HbA1C; Insulin; Type 1 diabetes mellitus

Indexed keywords

EID: 84860162394     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2011.03     Document Type: Article

References (17)

1. Vasudevan AR, Burns A, Fonseca VA. The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus. Treat Endocrinol 2006;5(5):273-286.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 Sep;329(14):977-986.
3. Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, et al; American Diabetes Association. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005 Jan;28(1):186-212.
4. Haller MJ, Stalvey MS, Silverstein JH. Predictors of control of diabetes: monitoring may be the key. J Pediatr 2004 May;144(5):660-661.
5. Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LM. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 2001 Aug;139(2):197-203.
6. Home PD, Lindholm A, Riis A; European Insulin Aspart Study Group. Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial. Diabet Med 2000 Nov;17(11):762-770.
7. Lalli C, Ciofetta M, Del Sindaco P, Torlone E, Pampanelli S, Compagnucci P, et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care 1999 Mar;22(3):468-477.
8. Hinde FR, Johnston DI. Two or three insulin injections in adolescence? Arch Dis Child 1986 Feb;61(2):118-123.
9. Gonen B, Rubenstein A, Rochman H, Tanega SP, Horwitz DL. Haemoglobin A1: An indicator of the metabolic control of diabetic patients. Lancet 1977 Oct;2(8041):734-737.
10. Dorchy H, Roggemans MP, Willems D. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience. Diabetes Care 1997 Jan;20(1):2-6.
11. Mortensen HB, Villumsen J, Vølund A, Petersen KE, Nerup J; The Danish Study Group of Diabetes in Childhood. Relationship between insulin injection regimen and metabolic control in young Danish type 1 diabetic patients. Diabet Med 1992 Nov;9(9):834-839.
12. Mortensen HB, Robertson KJ, Aanstoot HJ, Danne T, Holl RW, Hougaard P, et al; Hvidøre Study Group on Childhood Diabetes. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Diabet Med 1998 Sep;15(9):752-759.
13. Bougnères PF, Landais P, Mairesse AM, Jais JP, Jos J, Peyraud J, et al. Improvement of diabetic control and acceptability of a three-injection insulin regimen in diabetic adolescents. A multicenter controlled study. Diabetes Care 1993 Jan;16(1):94-102.
14. Schiffrin A, Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 1982 Sep-Oct;5(5):479-484.
15. Schiffrin A, Desrosiers M, Moffatt M, Belmonte MM. Feasibility of strict diabetes control in insulin-dependent diabetic adolescents. J Pediatr 1983 Oct;103(4):522-527.
16. Worth R, Home PD, Johnston DG, Anderson J, Ashworth L, Burrin JM, et al. Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br Med J (Clin Res Ed) 1982 Oct;285(6350):1233-1240.
17. Clements MR, Tits J, Kinsley BT, Rastam J, Friberg HH, Lightlm RJ. Improved glycemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes Diabetes. Obesity and Metabolism 2008;10:229-237.